Sight Sciences, Inc. is an innovation leader at the intersection of Interventional Glaucoma and Interventional Dry Eye, developing transformative, interventional technologies that allow eyecare providers to procedurally elevate the standards of care—empowering people to keep seeing. The Company focuses on minimally invasive procedural solutions that address the underlying causes of disease, targeting two large, growing, and underserved markets in eye care: glaucoma and dry eye disease. Its portfolio includes implant‑free technologies used in interventional glaucoma procedures, including the OMNI® Surgical System and SION® Surgical Instrument, and an interventional, procedural dry eye platform, TearCare® System, all of which are designed to enable earlier, physician‑directed intervention and durable treatment outcomes.
